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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S275surgical attempts, autologous chondrocyte implantation (ACI) was the ﬁrst
cell therapy approach developed for these kinds of lesions. Chondrocyte
usage nevertheless is limited by the dedifferentiation occurred when
expanded in monolayer. Bone marrow-derived Mesenchymal Stem Cells
(MSC) emerge as ideal cells to be implanted in the site of cartilage lesions.
Methods: Here we use MSC to treat sheep cartilage lesions implanted in
the upper cartilage layer of bilayered PLLA scaffolds, which hold a lower
layer enriched with Hydroxiapatite to facilitate osteointegration of the
scaffold.
Results: After evolutions of 1.5, 3 and 6 months, lesions showed a slight
but non signiﬁcant decrease in the mankin score for cartilage found in the
lesioned area (in animals treated with unloaded and cell loaded scaffolds)
suggesting a progressive degradation of the tissue. Nevertheless, staining
with Safranine-O showed the presence of more cartilaginous tissue in
animals evolve for 6 months with MSC loaded scaffolds, demonstrating
a more regeneration of the tissue when MSC were implanted in cartilage
lesions. Unfortunately new formed tissue did not appear in the cartilage
layer, but inside the hole performed during surgery, which might suggest
some incapacity of the scaffold to support the presence of cells aligned
with the surface in order to integrate tissue to the surrounding cartilage.
Finally, collagen type II and aggrecanwere found in the regenerated tissue.
Conclusions: The use of MSCs is a promising alternative for the treatment
of cartilage damage, but administration in the core of scaffolds needs to be
improved.
546
MESENCHYMAL STEM CELL THERAPY IN A RAT MODEL OF
OSTEOARTHRITIS
G.M. van Buul 1, M. Siebelt 1, M.J. Leijs 1, P. Bos 1, J.H. Waarsing 1, N. Kops 1,
H. Weinans 1,2, J.A. Verhaar 1, M.R. Bernsen 1, G.J. van Osch 1. 1 Erasmus MC,
Rotterdam, Netherlands; 2Delft Univ. of Technology, Delft, Netherlands
Purpose: Mesenchymal stem cells (MSCs) are promising candidates for
cartilage regeneration and osteoarthritis (OA) therapies, due to their ability
to form cartilage and to secrete immunomodulatory factors. Since OA
comprises many different processes, we evaluated the effects of intra-
articularly injected cultured MSCs on multiple aspects of OA pathology,
including pain, cartilage degeneration and subchondral bone changes, in
a rat model in vivo. In order to explore potential options to enhance clinical
translatability, we studied rat- and human cultured MSCs, as well as
freshly isolated rat bone marrow mononuclear cells (BMMNCs).
Methods: Osteoarthritis was induced unilaterally in 32 male wistar rats
(16 weeks old) by intra-articular injection with 300 mg mono-iodoacetate
(MIA). Three weeks after OA induction rats were randomly divided into
four treatment groups: 1. Control (saline); 2. Rat MSCs; 3. Rat BMMNCs and
4. HumanMSCs. Rat MSCs and humanMSCs were given at a dose of 1 x 106
cells in 50ul saline per joint, rat BMMNCs were given at a dose of 10 x 106.
Rats where euthanized four weeks after treatment injections. Before and
after OA induction, as well as 4 weeks after treatment, hind limb weight
distribution between the osteoarthritic and the contralateral healthy joint
was used as an index of joint discomfort. Ex vivo uCT analysis was per-
fomed to assess changes in the subchondral bone plate and histology was
used to evaluate loss of glycosaminoglycans and development of structural
damage in the cartilage at the endpoint of the study. Statistical analysis
was performed with repeated measures ANOVA and paired t-tests for hind
limb weight distribution, with one way ANOVA and unpaired t-tests for
mCT data, and with non-parametric Kruskal-Wallis and Mann-Whitney-
tests for histology scores. For all tests, p values <0.05 were considered
statistically signiﬁcant.
Results: Hind limb weight distribution (Figure 1): After MIA injection,
signiﬁcantly less weight was distributed to the affected leg compared to
baseline (P < 0.001), indicating pain sensation. The rats treated with rat
MSCs distributed signiﬁcantly more weight to their affected paw 4 weeks
after treatment than before treatment (P ¼ 0.003), whereas none of the
other groups showed a signiﬁcant change in weight distribution. The
groups however, did not differ statistically signiﬁcant at the endpoint of
the study.
Subchondral bone changes: MIA injected knees had a signiﬁcantly more
porous (P < 0.001) and thinner (P ¼ 0.005) subchondral plate than controlknees. Rats treated with rat MSCs or rat BMMNCs showed the least sub-
chondral bone changes, although no statistically signiﬁcant differences
between treatment groups were observed.
Cartilage quality: Knees injected with MIA had lost GAG and developed
structural damage (P< 0.001 for both compared to control knees). Median
GAG loss and structural damage was less in the group treated with rat
MSCs than in the saline treated group, albeit no signiﬁcant differences
were found between any of the treatment groups.
Conclusions: The treatment with injection of rat MSCs caused a signiﬁcant
increase in weight distributed to the affected limb, indicating a reduction
of joint discomfort. This is the ﬁrst study that evaluates the effect of cell
therapy on pain in a small animal OAmodel. In addition, the injection of rat
MSCs caused a trend towards reduction of cartilage and subchondral bone
changes, albeit no signiﬁcant differences were observed between any of
the treatment groups. The absence of statistically signiﬁcant effects of the
treatments on cartilage and bone structure might be related to several
factors, including the time of injection, the OA model or the number of
injected cells. To improve treatment effect, cell number, cell type and the
time point of treatment should be further optimized.
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Purpose: Functional repair of critical size articular cartilage defects is still
a considerable challenge in the ﬁeld of tissue regeneration. To effectively
improve the quality and durability of tissue-engineered neocartilage
a better understanding of microenvironmental cues provided from
surrounding cartilage and subchondral bone tissue and the modulating
inﬂuence of neighbouring cells and tissue interfaces in vivo on chondro-
genic differentiation of MSC are essential.
This study is designed to identify microenvironmental conditions which
promote, prevent or interfere with chondrogenic differentiation of
mesenchymal stem cells (MSC) and to analyse their impact on hyaline
cartilage like quality and biomechanical properties of regenerated tissue.
